Safety and efficacy of intensive vs. guideline antiplatelet therapy in high‐risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)

Publisher: John Wiley & Sons Inc

E-ISSN: 1747-4949|10|7|1159-1165

ISSN: 1747-4930

Source: INTERNATIONAL JOURNAL OF STROKE, Vol.10, Iss.7, 2015-10, pp. : 1159-1165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content